- Efficacy and impact of PARPi monotherapy to subsequent platinum-based chemotherapy in BRCA1/2 mutant ovarian cancer patients with secondary platinum-sensitive relapse
-
Kun S, Ma Y, Bu H, Kong B
- KMID: 2537930
- J Gynecol Oncol.
- 2022 Aug;33(S1):S6.
- doi: 10.3802/jgo.2022.33.S6
Objective The therapeutic effect of poly(ADP-ribose) polymerase inhibitors (PARPi) monotherapy compared with platinum-based chemotherapy, and the impact to subsequent platinum-based chemotherapy after PARPi resistance were inconclusive. Methods BRCA1/2 mutant ovarian cancer patients with... -
- CITED
-
- Close
- SHARE
-
- Close
